Live News Categoriesmarket

MEDP.US.EQUI (MEDP.US.EQUI) News

Follow MEDP.US.EQUI (MEDP.US.EQUI) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 1 public stories across 1 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.

Symbol MEDP.US.EQUI Asset market Sector Markets 90 days 1 Updated Jul 08, 2026, 09:28 AM UTC Open live news feed

H Medpace downgraded to Neutral from Outperform at Baird Baird analyst Eric Coldwell downgraded Medpace to Neutral from Outperform with a price target of $547, up from $477. not While "not worried" about 2026 guidance, the analyst says the stock "is a Yo-Yo and day-of-reportin EQUITY | Jul 08, 2026, 09:28 AM UTC